Eledon Pharmaceuticals Inc (NASDAQ:ELDN) does about 101.75K shares in volume on a normal day but saw 2523275 shares change hands in Tuesday’s trading. The company now has a market cap of 54.69M USD. Its current market price is $2.26, marking a decrease of -7.38% compared to the previous close of $2.44. The 52 week high reached by this stock is $2.95 whilst the lowest price level in 52 weeks is $1.07.
Eledon Pharmaceuticals Inc (ELDN) has a 20-day trading average at $2.02 and the current price is -23.39% off the 52-week high compared with 111.21% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.87 and its 200-day simple moving average is $1.57. If we look at the stock’s price movements over the week, volatility stands at 9.01%, which increases to 11.46% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 58.08 to suggest the stock is neutral.
The consensus objective for the share price is $16.20, suggesting that the stock has a potential upside of 86.05% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 13, 2022 when Cantor Fitzgerald resumed the stock to “Overweight” and issued a price target of between $25 and $15.
Eledon Pharmaceuticals Inc (ELDN) stock is down -5.44% over the week and 30.64% over the past month. Its price is 25.56% year-to-date and -15.67% over the past year.
To reach the target analysts have set, the stock logically needs to grow 86.05 percent from here.
The company has a return on investment of -48.34% and return on equity of -48.12%. The beta has a value of 0.73. Price to book ratio is 0.66.
